The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator? by Behrens, Ron H et al.
Behrens, RH; Carroll, B; Hellgren, U; Visser, LG; Siikamki, H; Vester-
gaard, LS; Calleri, G; Jnisch, T; Myrvang, B; Gascon, J; Hatz, C
(2010) The incidence of malaria in travellers to South-East Asia: is
local malaria transmission a useful risk indicator? Malar J, 9. p. 266.
ISSN 1475-2875
Downloaded from: http://researchonline.lshtm.ac.uk/2511/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
RESEARCH Open Access
The incidence of malaria in travellers to
South-East Asia: is local malaria transmission
a useful risk indicator?
Ron H Behrens1,2*, Bernadette Carroll1, Urban Hellgren3, Leo G Visser4, Heli Siikamäki5, Lasse S Vestergaard6,
Guido Calleri7, Thomas Jänisch8, Bjørn Myrvang9, Joaquim Gascon10, Christoph Hatz11
Abstract
Background: The presence of ongoing local malaria transmission, identified though local surveillance and reported
to regional WHO offices, by S-E Asian countries, forms the basis of national and international chemoprophylaxis
recommendations in western countries. The study was designed to examine whether the strategy of using malaria
transmission in a local population was an accurate estimate of the malaria threat faced by travellers and a correlate
of malaria in returning travellers.
Methods: Malaria endemicity was described from distribution and intensity in the local populations of ten S-E
Asian destination countries over the period 2003-2008 from regionally reported cases to WHO offices. Travel
acquired malaria was collated from malaria surveillance reports from the USA and 12 European countries over the
same period. The numbers of travellers visiting the destination countries was based on immigration and tourism
statistics collected on entry of tourists to the destination countries.
Results: In the destination countries, mean malaria rates in endemic countries ranged between 0.01 in Korea to
4:1000 population per year in Lao PDR, with higher regional rates in a number of countries. Malaria cases imported
into the 13 countries declined by 47% from 140 cases in 2003 to 66 in 2008. A total of 608 cases (27.3%
Plasmodium falciparum (Pf)) were reported over the six years, the largest number acquired in Indonesia, Thailand
and Korea. Four countries had an incidence > 1 case per 100,000 traveller visits; Burma (Myanmar), Indonesia,
Cambodia and Laos (range 1 to 11.8-case per 100,000 visits). The remaining six countries rates were < 1 case per
100,000 visits. The number of visitors arriving from source countries increased by 60% from 8.5 Million to 13.6
million over the 6 years.
Conclusion: The intensity of malaria transmission particularly sub-national activity did not correlate with the risk of
travellers acquiring malaria in the large numbers of arriving visitors. It is proposed to use a threshold incidence of > 1
case per 100,000 visits to consider targeted malaria prophylaxis recommendations to minimize use of
chemoprophylaxis for low risk exposure during visits to S-E Asia. Policy needs to be adjusted regularly to reflect the
changing risk.
Background
There is some evidence of declining malaria imported
from Central and South America, the Indian sub continent
and from West Africa [1-3]. Policy recommendations for
the use of prophylaxis need to be adjusted to reflect the
changing risk. Prophylaxis recommendations for travellers
are published by a number of organisations and national
bodies. The Swiss/German/Austrian policy group, recog-
nized the change in travel associated risk in 2007 [4,5],
and adjusted their chemoprophylaxis recommendations
for travellers to the S-E Asian region but advise travellers
to carry standby treatment during their journey. Other
national bodies, including CDC [6], ACMP [7] Simet [8]
THL, Finland [9], CMVI France [10] and WHO [11] have
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maintained their recommendations for the use of chemo-
prophylaxis to most countries where specific regional dif-
ferences in incidence of malaria are reported.
Malaria prevention policy makers use a mixture of
sources when deciding recommendations. Many rely on
the presence or absence of malaria by species, in the coun-
try or region. Others use a combination of local malaria
transmission, expert opinion and burden of disease in
returned travellers to inform policy. What is not described
in most policies are the methods or sources of malaria
distribution, burden in returned travellers, and the expert
opinion selection and qualifications to provide a transpar-
ent policy process. This means the balance between
malaria threat and adverse events arising from chemopro-
phylaxis is unclear. The recommendations include advice
on undertaking a risk assessment when selecting a prophy-
laxis strategy but most do not provide the epidemiological
information necessary for their decision-making. This
study is aimed at providing policy makers’ evidence of the
malaria risk faced by travellers to popular countries and
regions of S-E Asia based on existing data and examine
whether the current practice of deciding chemoprophy-
laxis policy, based on the geographical distribution of para-
sites, reflects the risk of travel associated malaria.
Methods
Malaria acquired during travel was collated through case
reports to national malaria surveillance bodies of 12
European countries and the USA. These countries pro-
viding data have been designated in the manuscript as
source countries. The case reports do not contain details
of the regions visited within countries or details of mul-
tiple countries visited during a journey. Malaria cases
from France are provided through a reporting network
of 120 selected hospital laboratories covering approxi-
mately half of the annual estimates of malaria cases to
the Malaria National Reference Centre (CNRPalu).
Popular SE Asia countries, visited by travellers have been
designated as destination countries shown in Table 1.
The geographical distribution of malaria in the desti-
nation countries and the local population’s malaria inci-
dence, are based on WHO country reports from the
most current published year. WHO regional offices in
the Western Pacific and South East Asian Regions pub-
lish annual data provided by their member countries
[12-21]. The incidence is expressed as cases (some
laboratory confirmed) per 1,000 population per annum
(PA). Literature reports describing the geographical dis-
tribution of malaria were used to supplement the WHO
assessment of endemic transmission.
The denominator used in the study is the numbers of
visitors from source countries arriving in the destination
countries collated from embarkation/disembarkation
cards completed for immigration and tourism purposes
on arrival. Hotel registration information collated by
national tourism offices provided regional visits for
China, Indonesia and Malaysia. These are used to define
source visitors to regions where there is a malaria risk.
Results
A summary of the most recent malaria epidemiology
assessment in the destination countries from informa-
tion to regional WHO offices is examined and covers
the most recent data provided by the country. The
national annual incidence rates are expressed as annual
parasite index (API) per 1,000 population per year. The
regions and/or provinces with ongoing transmission are
identified with their maximum and minimum range of
API per 1,000 population per annum (PA) (Table 2)
Cambodia
Of the 12 million population, around half a million live
in forested areas with high malaria transmission. Since
2003 the incidence of malaria declined from 7:1,000 to
3:1,000 population [19]. The main provinces with
malaria transmission are Battambang, Kampong Speu,
Pursat, Preah Vihear, Mondukiri, Rattanakiri, Palin. (3.9-
44.5:1,000 PA) [22]. Siem Reab has a population of
908,090 with a reported incidence of 3.7 cases of Pf per
1,000 PA. Phnom Penh receives the majority of the
remaining tourists and has around 40 cases per annum
occurring in its 1.4 million residents. The province of
Siem Reab which includes the popular tourist complex
of Angkor Wat, attracted half of the 2.3 million tourists
to Cambodia in 2008 [23]. The source countries made
up around 540,000 of this total (Table 1)
Vietnam
Of the 63 provinces of Vietnam only 8 (Quang Nam, Gia
Lai, Khanh Hoa, Quang Tri, Binh Phuoc, Ninh Thuan, Dal
Lak, Kon Tum) are reported to have malaria with an inci-
dence greater than >1:1,000 population per year (1.2-2.7).
The nationwide incidence of malaria morbidity fell from
0.45:1,000 (2003) to 0.2:1000 PA in 2007 [17]. Of the 2.6
million tourists arriving in Vietnam in 2008, approximately
1 million were from the source countries [24].
China
Of China’s 21 provinces, the southern border provinces
of Hainan, Anhui and Yunnan have a malaria transmis-
sion incidence of ~0.2:1,000 (0.13-1.0:1,000 population
PA [20]. The majority of cases in Yunnan are concen-
trated around the international borders. Three hundred
and seventy one thousand source visitors spent an aver-
age of 17 (range 11-25) nights in these three provinces
during 2007 [25]. China as a whole received 4 million
visits in 2008 from source countries who spent an aver-
age of 17 nights during their visit [25,26].
Behrens et al. Malaria Journal 2010, 9:266
http://www.malariajournal.com/content/9/1/266
Page 2 of 10
Thailand
The incidence of malaria has fallen from 0.86 (2003) to
0.55:1,000 populations in 2008 [13]. In an exposed
population of 47.4 million, around 26,000 laboratory-
confirmed cases are reported of which 47% are Plasmo-
dium falciparum. Eleven (Tak, Yala, Mae Hong son,
Narathiwat, Songkla, Ranong, Chanthaburi, Chumporn,
Kanchanabur, Petchaburi, Prachua Khiri Khan) of the 24
provinces of have an incidence > 1:1,000 PA (1.5-12.2)
[22]. The Thai-Cambodia and Thai-Myanmar borders
have multi drug resistant P. falciparum malaria. In 2007
3.7 million visitors from source countries spent an aver-
age of 14 days in Thailand, 2.5 (63%) million were inde-
pendent (non-package) travellers and 40% arrived in
Thailand for the first time [27].
Malaysia
Malaria transmission is minimal on mainland Malaysia,
with a country-wide incidence of 0.2:1,000 PA. The two
regions with the highest incidence are Sabah and Sara-
wak where the 2007 rates were 0.8 and 0.5:1000 PA.
Half of the cases in Sabah and 12% in Sarawak, are
P. falciparum [18]. Malaysia received 22 million visitors
[28]of which one million were from source countries
81,000 of whom visited Sarawak and 79,000 visited
Sabah in 2008 [29,30].
Indonesia
Indonesia has approximately half its population living in
malaria transmission areas and the highest endemicity is
in the outer islands of Papua, Maluku, Nusa Tenggara,
Table 1 Total numbers of visitors from source countries arriving in S-E Asia Countries
Destination 2003 2004 2005 2006 2007 2008
Burma (Myanmar) 60,762 54,374 53,922 71,496 35,668 26,481
Cambodia NA 483,995 361,191 409,700 492,832 539,527
China 3,100,420 2,740,800 3,386,500 3,835,054 4,274,453 3,990,818
Indonesia 689,768 814,515 906,182 771,572 815,166 947,611
Korea 650,531 770,423 812,636 853,831 912,625 969,378
Laos 117,386 139,773 169,030 174,750 179,272 190,028
Malaysia 433,750 558,170 638,039 712,820 840,570 1,064,725
Philippines 555,879 679,011 754,805 806,865 852,828 871,581
Thailand 2,525,486 2,826,173 3,023,280 3,539,994 3,738,843 3,965,194
Vietnam 368,900 504,075 605,300 829,738 983,002 1,010,738
Source countries millions 8.5 M 9.6 M 10.7 M 12.0 M 13.1 M 13.6 M
All Foreign Arrivals millions 46.9 M 62.6 M 67.5 M 73.8 M 84.1 M 83.1 M
Data from [23,24,26-28,32,36,37].
M = millions of visits.
Table 2 S-E Asian countries with incidence, regional transmission and total visits from source countries
National API Mean
(range) *
Endemic+
Provinces
Source
Visits
Imported
cases
Mean incidence
cases:100,000 visits
95%
CI
Avg. duration of visit
(days)
Burma
(Myanmar)
2.8 (3.5-48) 10/17 302,703 31 11.80 7.69 NA
Cambodia 3.0 (3.9 -44.5) 7/24 2,287,245 45 1.16 0.76 6.6
China < 0.01 (0.01-1.0) 3/21 21,328,045 25 0.13 0.14 17.0
Indonesia 3.8 (1-876) 17/30 4,944,814 283 3.69 2.81 13.10
Korea 0.01 (0.01-0.2) 2 4,969,424 46 0.25 0.04 NA
Laos 4 (0.78-40.0) 15/17 970,239 9 1.04 0.94 NA
Malaysia 0.2 (0.01-0.8) 2/15 4,248,074 14 0.37 0.26 NA
Philippines 0.4 (1.6-13) 25/65 4,520,969 22 0.51 0.31 23.0
Thailand 0.55 (0.4-14.5) 11/24 19,618,970 118 0.60 0.13 15.5
Vietnam 0.2 (0.6-2.7) 8/63 4,301,753 15 0.47 0.43 NA
* API of highest and lowest malaria endemic province.
+ Provinces with malaria transmission and all provinces.
S-E Asian countries with incidence regional transmission and total visits from source countries. The mean and SD is calculated from all cases and visits to the
country by source visitors over the 6 period. The average duration of visit applies to the all visitors to the country based on 2008 data. NA = not available.
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Sulawesi, Kalimantan, and Sumatra, and 17 provinces
are reported to have malaria transmission. The average
rate across the country is 5:1,000 PA [12]. In high ende-
mic regions, such as Timika in Papua, the incidence has
been reported to be as high as 876 per 1,000 PA [31].
Of the 5.5 million visitors to Indonesia, 947,611 origi-
nated from the source countries in 2008 remaining for
an average of 13 days. Approximately half of all visitors
in 2007, registered in accommodation in the endemic
malaria regions for an average of 2.5 days. Of these only
67,000 were from source countries [32].
Laos
A very recent national survey of the distribution of
malaria revealed that 35% of the population lived in
areas with no transmission of malaria [33]. The study
was based on rapid diagnostic analysis in health centres
over a three year period 2006-2009, P. falciparum is
highly heterogeneous in the northern and central
regions of the country with large areas of no transmis-
sion. In the South of the country, there is an increased
risk, and there are pockets of very high and low risk and
overall a lower risk of malaria for much of the popula-
tion than previously described. Seven provinces, Sara-
vane, Savannakhet, Sekong, Attapeu, Champasack,
Khammouan, Phongsaly had an incidence above 1 case
per 1,000 PA, with four provinces having a median of
> 1 (4.7-23.5) [33]. The border regions with Vietnam
had a particularly high transmission. The Lao Peoples
Democratic Republic received 1.4 million visitors in
2007 of whom 180,000 were from source countries [34].
Myanmar
More than 40 million people live in malarious areas in
Myanmar, with about 4.2 million malaria cases estimated
each year (about 20% of all cases in the WHO South East
Asia Region), so that malaria is the most important pub-
lic health problem in this country, and a priority in health
planning. Most vulnerable are non-immune migrant
workers, employed in rural and forest areas [14,35].
The malaria burden has steadily increased throughout
the last 40 years, despite a decline between 2004 and
2005. The P. falciparum proportion has slowly declined,
from 89% in 1988 to 75% in 2009, with Plasmodium
vivax replacing it. There is an overall incidence of
10 cases per 1,000 population [14]. Regions with higher
incidences include Magway, Mon, Sagaing, Taninthayi
Division, Northern Shan State, Kachin State, Rakhine
State, Chin State (6.9-48.5:1000 PA) [22] and most
forested areas. Multidrug resistant P. falciparum is
spreading, with mefloquine and quinine resistance
increasing in the Thai-Myanmar border region. Of the
total 100,500 tourist arrivals in Burma, 26,500 were
from source countries in 2008 [36].
Philippines
Malaria in the Philippines has a countrywide incidence of
0.41:1,000 PA [15,35]. The majority of cases occur in 25
of its 65 provinces with 70% of cases reported from Pala-
wan, Tawi-Tawi, Sulu, Apayao, Davao del Sur Cagayan
(1.6-13:1000 PA) [15]. The total number of overseas visi-
tors to the country was 2.94 million, for an average of
23 days. Visitors from the source countries made up
871,000 of this total in 2008. Over half a million of these
originated from the USA [37].
Republic of Korea
All cases are caused by P. vivax. The highest risk is
associated with the Demilitarized Zone with most cases
occurring in military personnel stationed in that area.
In 2007, 2,192 cases of Plasmodium vivax were con-
firmed in the local population [16]. In 2008, 6.9 million
visitors arrived in Korea of whom 969,378 were from
source countries [38].
Malaria imported from destination countries
Over the six-year period a total of 608 cases of malaria
were included in the study reported by the source coun-
tries (Table 3). Table 4 details the malaria species with,
P. falciparum (166), P. vivax (349), Plasmodium ovale
(11), Plasmodium malariae (5) and Plasmodium know-
lesi (3) and not-specified (65). The total number of
malaria cases range from 140 cases in 2003 to 66 cases
in 2008 (47% reduction) as reported by source country
surveillance bodies, detailed in Table 5. Plasmodium
falciparum constituted 30.3% of identified Plasmodium
species during the study period. Table 6 shows all the
malaria cases by county of probable acquisition by year
reported. The national mean endemic rates of malaria
transmission are detailed in Table 2. This also shows
the range of rates from lowest to highest in endemic
provinces or regions where populations are living under
risk of malaria. Figure 1 shows the trend of imported
malaria during the study period.
Malaria incidence in visitors to destination countries
The malaria incidence is expressed as malaria case(s)
per 100,000 visits with the mean for the six-year period.
In destination countries where regional data of visits
were available, the risk was assessed for the endemic
region. Table 2 details the national incidence of all
malaria using all species reports, and visits from source
countries. The risk of malaria to endemic regions of
Malaysia (Sabah & Sarawak) China (Yunnan, Hainan
Anhui) and Indonesia (17 provinces) where transmission
is regional was examined. Assuming that all cases of
malaria reported were acquired in these endemic
regions; in China during 2008, (371,000 visitors), there
were three cases reported in travellers, in Sabah and
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Sarawak (161,000 visitors) there was a single case. Indo-
nesia has the most cases reported, with 16 cases of
P. vivax and two cases of P. falciparum, four other spe-
cies and an estimated 67,000 visitors to the endemic
provinces, based on hotel and guest house statistics
[29,30]. The mean risk of malaria over the six-year per-
iod is shown in Table 2 as cases per 100,000 visits. Four
countries, Burma and Indonesia, Cambodia, and Laos
had a six-year average incidence of >1:100,000 visits.
However none of the other countries over the six-year
period achieved a rate greater than one case per 100,000
visits and in both Cambodia and Laos during 2007-2008
rates had fallen below this level.
Visits to destinations countries
The use of national immigration and tourism statistics
has enabled a more precise estimate of travellers entering
destination countries who may be exposed to malaria
and provides a denominator for malaria acquired in these
countries. The immigration data are detailed by the
country of residence of the visitor, and from some coun-
tries the duration, reason for visit and province/city
visited and type of accommodation is collected. Table 1
and Table 7 describes the increasing numbers of travel-
lers by source countries arriving at their destination
country who represent 7.25% of all foreign arrivals. The
13.6 million visitors in 2008, was an increase of 60% from
the totals in 2003 (Table 1 and Figure 1).
Discussion
Chemoprophylaxis recommendations are decided by a
number of policy groups, both nationally and interna-
tionally. Many appear to base their recommendations on
the malaria transmission and activity reported in S-E
Table 3 All malaria cases reported by source countries and country of likely acquisition 2003-2008
Burma (Myanmar) Cambodia China Indonesia Korea Laos Malaysia Philippines Thailand Vietnam Total
Belgium 0 0 0 9 0 0 1 0 2 0 12
Denmark 0 1 1 8 0 0 1 0 4 0 15
Finland 0 1 0 0 0 0 1 0 5 0 7
France 4 12 0 34 0 2 3 4 12 2 73
Germany 7 6 0 37 2 1 2 2 20 3 80
Italy 2 0 10 21 0 0 2 0 10 1 46
Netherlands 0 2 0 61 0 0 0 3 4 0 70
Norway 1 0 1 1 0 0 0 1 3 0 7
Spain 0 1 0 4 0 0 0 2 2 0 9
Sweden 1 2 0 16 0 1 1 0 11 0 32
Switzerland 1 2 1 27 1 2 0 0 7 2 43
UK 2 6 2 16 2 1 1 2 9 0 41
USA 13 12 10 49 41 2 2 8 29 7 173
Total 31 45 25 283 46 9 14 22 118 15 608
Cases were collated through national surveillance system in the source countries.
Table 4 Malaria species in source countries by year of
report
Species 2003 2004 2005 2006 2007 2008 Total
P. falciparum 47 34 24 22 22 17 166
P. vivax 82 63 61 41 60 42 349
P. ovale 2 3 3 1 1 1 11
P. malariae 1 1 1 1 1 0 5
P. knowlesi 0 0 0 0 2 1 3
unspeciated
plasmodium
7 18 12 14 10 4 65
mixed cases 1 0 2 3 2 1 9
Laboratory diagnosed species as reported to respective surveillance bodies.
Table 5 Numbers of malaria cases reported by source
countries
2003 2004 2005 2006 2007 2008 Total
Belgium 5 4 1 0 0 2 12
Denmark 2 6 1 2 2 2 15
Finland 0 0 1 0 4 2 7
France 17 17 7 11 10 11 73
Germany 24 16 14 11 5 10 80
Italy 14 6 12 5 4 5 46
Netherlands 19 22 16 5 5 3 70
Norway 0 4 1 2 0 0 7
Spain 1 3 1 2 0 2 9
Sweden 8 7 6 4 6 1 32
Switzerland 8 7 10 5 5 8 43
UK 13 7 4 8 5 4 41
USA 29 20 29 27 52 16 173
Total 140 119 103 82 98 66 608
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Asian countries, which are often historical from 2-5 years
previous. Most policy documents do not state the metho-
dology, data sources or risk analysis used in their deci-
sion-making. The basis of risk is, therefore, presumed to
be predominantly linked to local or regional transmission
based on WHO reports or undeclared source(s).
The popularity of S-E Asian destinations is reflected
by the volume of travel to this region. During 2008, 13.6
million travellers from the 13 source countries entered
the ten S-E Asian countries, constituting less than 8% of
all foreign visitors. This denominator has for the first
time, been based on data collated by local immigration
and tourism infrastructure and provides the most repre-
sentative denominator of arriving travellers. These data,
which stem from all of the countries, are annually
maintained, which makes the calculation of incidence
straightforward. Currently, a number of other denomi-
nator sources are used to provide number of travellers,
so a limited comparison was attempted. The United
Nations World Tourism Organisation (WTO) arrivals
are based on ticket sales and is one of the most widely
used source of numbers of travellers to a county or
region. The WTO figure for arrivals in China was 240%
higher than the China National Statistics Office figure in
the two years 2003 and 2004 [25,26]. Another denomi-
nator source for UK travellers is the International Pas-
senger Survey (IPS) [39] which uses a sampling method
interviewing departing passengers. A comparison of the
IPS and Thailand Tourism data on numbers of UK tra-
vellers to Thailand over the study period enabled a com-
parison between two denominator sources. The IPS
estimate was half (47%-57%) the numbers of UK arrivals
reported by the Tourism Authority of Thailand. This
comparison suggests there are significant differences in
estimates of visitor arrivals by the different sources.
Malaria surveillance reports may be imprecise with
regard to the actual country of infection as travellers often
visit many countries within the region. If a clinical episode
develops during travel, it will not be included in the
national surveillance, further reducing the accuracy of
these reports. This may not be a frequent problem, as
detailed by The Hospital for Tropical Diseases in Bangkok,
Thailand. Bangkok is a city which provides a popular start-
ing point for travellers to the wider region. The Hospital
for Tropical Diseases treated only 11 (5 P. vivax.) cases of
malaria in travel acquired in S-E Asian countries (three
from Thailand) between 2000-2005. During that period
Table 6 All travel cases by country of acquisition by year
of report
Country malaria
acquired
2003 2004 2005 2006 2007 2008 Total
Burma (Myanmar) 5 5 4 4 9 4 31
Cambodia 16 6 6 9 4 4 45
China 12 4 3 1 2 3 25
Indonesia 63 63 58 38 38 23 283
Korea 10 9 4 5 16 2 46
Laos 3 2 2 0 1 1 9
Malaysia 2 2 5 1 3 1 14
Philippines 5 4 2 6 4 1 22
Thailand 20 20 16 17 18 27 118
Vietnam 4 4 3 1 3 0 15
Total 140 119 103 82 98 66 608
Figure 1 The trend of all imported malaria from, and travel to S-E Asia between 2003 and 2008. The trend of imported malaria and
numbers of visitors to the 13 countries over 6 years. Malaria cases fell by 47% while visits to the region increased by 60%.
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20.1 million European and North Americans visited Thai-
land alone, for an average of 14 days [27] This represents
a malaria incidence of < 0.01 case per 1,000 years expo-
sure. A number of European countries, recognizing the
low incidence of malaria, recommend the carriage of
standby malaria therapy for travellers to the SE Asian
region in place of chemoprophylaxis [40,4]. This policy
ensures quality of drug can be assured as the prevalence of
counterfeit and fake anti-malarial drugs in the region is
high. Early self administration allows clearance of both
P. falciparum and primary attacks of P. vivax infection
which will reduce morbidity in true malaria cases and cur-
rent therapeutic drugs are effective with minimal side-
effects. The disadvantage is that all travellers (13.6 million)
in this study need to carry treatment from which very few
will benefit. Most treatments will not be for malaria, but
for non-specific fever [41]. The life-saving advantage of
standby therapy would be marginal as 70% of malaria
acquired during 2008 from S-E Asia was with the less
severe P. vivax for which standby treatment will not elimi-
nate latent infection. A total of 17 cases of P. falciparum
were reported that year acquired in Thailand (six), Burma
(Myanmar)(three), Cambodia, Laos and Indonesia (two
cases each).
A survey of backpackers in Bangkok who were travelling
throughout this region described only 22% of interviewed
subjects using chemoprophylaxis. A small proportion, 15%
had visited forested regions during their journey where
malaria is considered a risk. Most backpackers appreciated
the risk of malaria, but were poorly compliant with perso-
nal protective measures and chemoprophylaxis [42] It is,
therefore, unlikely that the low malaria incidence seen
in most countries is because of the use of malaria preven-
tative measures by travellers. Within the period of the
Thai study (1998-2007), the Mekong countries (6 of 10)
reported a 60% reduction in the annual number of local
deaths attributed to malaria, and a 25% reduction in the
number of confirmed cases, with Myanmar accounting for
half of all reported cases [22]. This decline in transmission
fits with the decreasing numbers of cases acquired by
travellers despite a 12% increase in visits to the region.
The low numbers of malaria cases acquired in the
most popular countries China, Malaysia, Thailand and
Vietnam suggests that these countries, including their
endemic provinces, pose a minimal threat to visitors.
Current chemoprophylaxis recommendations may be
accurately targeting visitors to these regions and may
prevent malaria. This explanation is not supported by
the evidence from Switzerland, [41] and Japan [43],
countries which do not recommend chemoprophylaxis,
but have similar or lower numbers of malaria cases in
their travellers to these areas. An alternative explanation
is that travellers do not visit the malaria endemic pro-
vinces. This does not fit the travel data presented here
where half of all Cambodian arrivals are to Siem Reap
International airport (designated by most current guide-
lines, as a risk region in Cambodia) and at least 300,000
visitors per year visit China’s malaria endemic provinces.
Current travellers’ chemoprophylaxis policy appears to
use reported transmission in a province or country of
any species as an indication for chemoprophylaxis. Most
policies do not describe whether transmission intensity
or species prevalence influence their recommendations.
Comparing the malaria risk to travellers visiting
Burma (Myanmar) and Cambodia, which have similar
mean national transmission rates, the actual numbers of
imported malaria cases are similar (31 and 45 respec-
tively) but the incidence in Burma (Myanmar) is 11.8
Table 7 Arrivals by year from Source countries to S-E Asian countries as reported through their immigration, tourist
collection and statistical reporting systems
Departures from: 2003 2004 2005 2006 2007 2008 Totals
Belgium 92,451 101,423 92,646 200,495 216,401 215,089 0.9 Million
Finland 88,148 99,676 110,563 159,881 205,039 217,571 0.9 Million
Denmark 128,087 141,446 155,272 199,720 225,323 248,520 1.1 Million
Norway 113,098 123,354 135,386 220,722 237,990 264,597 1.1 Million
Spain 74,786 109,265 104,236 308,049 344,391 313,133 1.3 Million
Switzerland 212,284 256,911 266,936 319,966 335,341 341,797 1.7 Million
Italy 244,584 351,081 412,932 479,058 528,072 517,281 2.5 Million
Sweden 329,012 391,600 423,353 561,225 665,212 681,872 3.1 Million
Netherlands 370,878 434,818 504,335 607,181 664,011 729,697 3.3 Million
France 2,066,956 790,388 1,099,828 1,192,356 1,367,880 1,443,833 8.0 Million
Germany 934,869 1,246,917 1,368,706 1,491,276 1,628,987 1,678,263 8.3 Million
UK 1,357,393 1,704,175 1,999,223 2,087,394 2,226,187 2,395,476 11.8 Million
USA 2,638,927 3,497,791 4,039,401 4,365,706 4,669,978 4,665,820 23.9 Million
Data from sources [23,24,26-28,32,36,37].
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times higher. This highlights the importance of using
incidence rather than absolute cases to define risk, and
that the national average does not correlate with travel-
lers risk. The relationship between endemic malaria
transmission and travel-acquired malaria has been pre-
viously examined and found a similar poor correlation
between endemic malaria transmission and malaria risk
in visitors to Central and South America [1].
What should policy-makers use as a proxy of malaria
risk for travellers? Most countries (less so Burma and
Laos) have heterogeneous transmission sub-nationally
because of varied vectors and forest transmission. The
reported annual API across regions in the study countries
varied from < 0.01- 876 per 1,000 population PA. Only
four countries had national API’s >= 1:1,000 PA (Table 2).
However, many malaria endemic provinces and regions
had higher attack rates, in a wider national setting of low
transmission. However, despite high regional rates, very
low numbers of malaria imported from most countries
(except Indonesia) were seen. The two countries with
highest incidence in travellers were Burma (Myanmar)
and Indonesia (11.8 and 3.7 cases per 100,000 visits
respectively) although Thailand and Indonesia provided
two thirds of all cases. Indonesia has the highest endemic
transmission in its islands, and despite the highest num-
bers of 283 imported cases the overall national incidence
is lower than that of Burma (Myanmar). Using a denomi-
nator of 67,000 visits to malaria endemic provinces of
Indonesia, based on hotel room and guest house statistics
[32] and assuming all malaria cases were acquired in these
endemic regions, the traveller’s malaria incidence would
be 19 cases per 100,000 visits per year (2008) or 10 cases
per 1,000 years exposed. West African rates of falciparum
malaria in UK residents ranged between 10 - 52 cases per
1,000 years exposure in 2006 [3].
The threshold for withdrawing chemoprophylaxis pol-
icy may be focussed on countries with low endemic
transmission (<=1.0 per 1,000 PA) and/or a high propor-
tion of P. vivax (>70%). In areas where vivax infection
predominates, suppressive chemoprophylaxis may not be
the ideal option as it suppresses the first attack at best,
but does not prevent latent clinical episodes. Alterna-
tively post-exposure prophylaxis may be considered.
Policy could be focussed on the incidence of malaria
in travellers returning from destination countries. Sur-
veillance reports of imported malaria are collected by
most countries as is the probable country of infection.
The denominator data are accessible for nearly all coun-
tries in this region although it may not be as detailed
for some European countries.
Countries with rates <=1 case per 100,000 visits, con-
stitute a low risk and do not justify malaria chemopro-
phylaxis. Countries with rates >1 case per 100,000 visits
are a more variable risk, and targeted prophylaxis for
regional travel or standby therapy should be considered.
This strategy will limit widespread use of chemoprophy-
laxis for low risk travellers and reduce toxicity. National-
ity, travel itinerary and threshold of risk avoidance may
differ in different countries and influence this threshold,
which can be adjusted. The rationale and thresholds
decided by policymakers should be transparent.
The study identifies the value of incidence in travellers
as a more sensitive predictor of malaria risk for travellers,
particularly where there is sub national transmission. The
more precise estimates reduce overuse of chemoprophy-
laxis with more focussed recommendations. This would
reduce the well-established risk of side effects and not
inconsiderable costs of widespread use of medication.
Any policy should reflect both changing local transmis-
sion, for example where focal outbreaks are recorded,
and the decline in transmission following national inter-
vention programs or parasite drug resistance changes.
National or international bodies should describe the data
source used for informing policy and thresholds used
when recommending chemoprophylaxis for regions with
low numbers of imported cases. This could lead to a con-
sensus in recommendation from policy groups advising
travellers, which would improve travellers’ confidence in
their prophylaxis recommendation, particularly when
they make comparisons with their fellow travellers on the
variety of chemoprophylaxis regimens.
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